Cai Wan Yu - Net Worth and Insider Trading
Cai Wan Yu Net Worth
The estimated net worth of Cai Wan Yu is at least $0 dollars as of 2024-06-22. Cai Wan Yu is the Executives of Betta Pharmaceuticals Co Ltd and owns about 0 shares of Betta Pharmaceuticals Co Ltd (SZSE:300558) stock worth over $0. Details can be seen in Cai Wan Yu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cai Wan Yu has not made any transactions after 2018-04-11 and currently still holds the listed stock(s).
Transaction Summary of Cai Wan Yu
Cai Wan Yu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cai Wan Yu owns 1 companies in total, including Betta Pharmaceuticals Co Ltd (SZSE:300558) .
Click here to see the complete history of Cai Wan Yu’s form 4 insider trades.
Insider Ownership Summary of Cai Wan Yu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:300558 | Betta Pharmaceuticals Co Ltd | 2018-04-11 | Executives |
Cai Wan Yu Latest Holdings Summary
Cai Wan Yu currently owns a total of 1 stock. Cai Wan Yu owns 0 shares of Betta Pharmaceuticals Co Ltd (SZSE:300558) as of April 11, 2018, with a value of $0.
Latest Holdings of Cai Wan Yu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:300558 | Betta Pharmaceuticals Co Ltd | 2018-04-11 | 0 | 35.79 | 0 |
Holding Weightings of Cai Wan Yu
Cai Wan Yu Form 4 Trading Tracker
According to the SEC Form 4 filings, Cai Wan Yu has made a total of 0 transactions in Betta Pharmaceuticals Co Ltd (SZSE:300558) over the past 5 years. The most-recent trade in Betta Pharmaceuticals Co Ltd is the acquisition of 500 shares on April 11, 2018, which cost Cai Wan Yu around $32,525.
Insider Trading History of Cai Wan Yu
- 1
Cai Wan Yu Trading Performance
GuruFocus tracks the stock performance after each of Cai Wan Yu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cai Wan Yu is -13.78%. GuruFocus also compares Cai Wan Yu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cai Wan Yu within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cai Wan Yu's insider trading performs compared to the benchmark.
Performance of Cai Wan Yu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.7 | | | | | |
| Relative Return to S&P 500(%) | -5.94 | | | | | |
Cai Wan Yu Ownership Network
Cai Wan Yu Owned Company Details
What does Betta Pharmaceuticals Co Ltd do?
Who are the key executives at Betta Pharmaceuticals Co Ltd?
Cai Wan Yu is the Executives of Betta Pharmaceuticals Co Ltd. Other key executives at Betta Pharmaceuticals Co Ltd include Directors & executives Wang Jia Bing , and Directors & executives Ding Lie Ming .
Betta Pharmaceuticals Co Ltd (SZSE:300558) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Betta Pharmaceuticals Co Ltd (SZSE:300558) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Betta Pharmaceuticals Co Ltd (SZSE:300558) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Betta Pharmaceuticals Co Ltd (SZSE:300558)'s detailed insider trading history can be found in Insider Trading Tracker table.
Betta Pharmaceuticals Co Ltd Insider Transactions
Cai Wan Yu Mailing Address
Above is the net worth, insider trading, and ownership report for Cai Wan Yu. Currently GuruFocus does not have mailing address information for Cai Wan Yu.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
